Risk factor
Good trading liquidity
Profitability factor
Undervalued vs peers
About
AMOREPACIFIC Group, operating through its various divisions, is a global enterprise specializing in the production, distribution, and sale of beauty, personal care, and related merchandise. Its market reach extends across Asia, North America, and its native South Korea, as well as other international regions. The company's extensive product portfolio features a wide array of items, including cosmetics, fragrances, clinical skincare solutions, beauty devices, nutritional supplements for beauty, hair and body care essentials, oral hygiene products, and specialty tea items. These offerings are brought to market under numerous well-known brands, such as AMORE pacific, Sulwhasoo, LANEIGE, Mamonde, Innisfree, ETUDE, SIENU, HERA, HOLITUAL, primera, IOPE, HANYUL, LIRIKOS, OUTRUN, EASY PEASY, Espoir, RAREKIND, STEADY, SOON+, ODYSSEY, MIREPA, BRO&TIPS!, BE READY, enuf proj, GOUTAL, fradore, AESTURA, makeON, VITAl BEAUTIE, cubeme, Ryo, mise en scene, Fresh Pop, LABO-H, Ayunche, amos, HAPPY BATH, illiyoon, FILLVOID, MEDIAN, Boncho Study, Pleasia, and OSULLOC. Beyond its core beauty business, AMOREPACIFIC Group is also involved in the fabrication and commercialization of pharmaceuticals, glass, green tea, detergents, and organic compounds. Its activities further encompass the production, printing, and promotion of paper containers, product packaging services, the creation of industrial machinery, and the oversight of facilities. Established in 1945, the corporation was initially named PACIFIC Corporation before officially adopting the AMOREPACIFIC Group name in March 2011. Its global operations are directed from its headquarters situated in Seoul, South Korea.
Company Valuation
Based on key historical and expected multiples, the stock is undervalued relative to its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITDA,
Target Price
The average target price of 002790.KS is 39198 and suggests 60% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to